Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06732375 · ClinicalTrials.gov registry record · NA

Pilot Study of Mindset Moments Among Adolescent and Young Adult Cancer Survivors

A NA study of Cancer and Young Adult Cancer, sponsored by Duke University.

Recruiting
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT06732375: Recruiting NA study of Cancer and Young Adult Cancer, sponsored by Duke University.

NCT06732375 is a NA study of Cancer and Young Adult Cancer that is actively recruiting participants, run by Duke University. The registered enrollment target is 40 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06732375, a NA study of Cancer and Young Adult Cancer, is actively recruiting participants, sponsored by Duke University.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to evaluate the feasibility and acceptability of the Mindset Moments™ (MM™) program in managing psychological distress and resiliency in adolescent and young adult cancer survivors. Study participation will involve attending 8 weekly, one hour, live online group sessions and completing daily 5 minute activities such as guided imageries and CBT check in within the app. Participants will also be asked to complete an online survey at the time of enrollment and at 4 and 8 weeks.

Primary Outcome

8-measure short form to assess the severity of anxiety symptoms within the Patient-Reported Outcomes Measurement Information System (PROMIS) framework. The total score ranges from 8 to 40, where a higher score indicates greater anxiety.

Interventions

  • BEHAVIORAL Mindset Moments

Study Locations (1)

North Carolina

  • Duke Cancer Institute - Durham

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2025-06-13
Est. Completion 2026-09
Phase NA
Duke University

1,725 total trials

What NCT06732375 shows while recruiting

NCT06732375 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (99% lower).

The record links to 4 conditions, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which Mindset Moments is the first listed.

NCT06732375 reports a single indexed study location in North Carolina.

Frequently Asked Questions

What is clinical trial NCT06732375 about?

NCT06732375 is a clinical study titled "Pilot Study of Mindset Moments Among Adolescent and Young Adult Cancer Survivors". The purpose of this study is to evaluate the feasibility and acceptability of the Mindset Moments™ (MM™) program in managing psychological distress and resiliency in adolescent and young adult cancer survivors. Study participation will involve attending 8 weekly, one hour, live online group session...

What is the current status of trial NCT06732375?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2025-06-13. Estimated completion is 2026-09.

What conditions does trial NCT06732375 study?

This clinical trial studies the following conditions: Cancer, Young Adult Cancer, Distress, Psychological, Youth Cancer.

What interventions are being tested in trial NCT06732375?

The interventions under investigation include: Mindset Moments (BEHAVIORAL).

Who is sponsoring clinical trial NCT06732375?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06732375 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06732375's enrollment target sits among peer trials

40 461st of 615 higher than 146 of 615 other Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06732375, the US trial registry maintained by the National Library of Medicine. NCT06732375 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.